N
Nuvalent Inc
NASDAQ:NUVL
Nuvalent Inc
NASDAQ:NUVL
Price:
102.25
USD
-1.41%
Market Closed
Market Cap:
$8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nuvalent Inc
NASDAQ:NUVL
|
US |
|
M
|
Merus Power Oyj
OMXH:MERUS
|
FI |
|
T
|
TAV Havalimanlari Holding AS
IST:TAVHL.E
|
TR |
|
Shenzhen H&T Intelligent Control Co Ltd
SZSE:002402
|
CN |
|
8
|
888 Holdings PLC
OTC:EIHDF
|
GI |
|
GSE Systems Inc
NASDAQ:GVP
|
US |
|
Cencosud SA
SGO:CENCOSUD
|
CL |
|
Tokyo Electron Device Ltd
TSE:2760
|
JP |
Multiples-Based Value
The Multiples-Based Value of one NUVL stock under the Base Case scenario is hidden USD. Compared to the current market price of 102.25 USD, Nuvalent Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NUVL Multiples-Based Value
LOCKED
Multiples Across Competitors
NUVL Competitors Multiples
Nuvalent Inc Competitors
Nuvalent Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
N
|
Nuvalent Inc
NASDAQ:NUVL
|
8B USD | 0 | -18.9 | -17.9 | -17.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.6 | 37.4 | 40.8 | 41.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
